✨ Free AI Report
Kissei Pharmaceutical Co., Ltd.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Kissei Pharmaceutical Co., Ltd.
Company Research

Kissei Pharmaceutical Co., Ltd.: Business Overview, Financials & Competitive Analysis

Kissei Pharmaceutical Co., Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Focused specialty pharma player with strong R&D orientation in niche therapeutic areas showing steady revenue growth and strategic use of emerging technologies. The company reported revenue of $611.3M in 2025 with 16.9% growth year-over-year and a market cap of $1.4B. Kissei demonstrates solid fundamentals with focused specialty pharmaceutical.

What is Kissei Pharmaceutical Co., Ltd.'s industry? Kissei Pharmaceutical Co., Ltd. (kissei.co.jp) operates in Pharmaceuticals & Biotechnology - Specialty Pharmaceuticals. AskCyborg classifies Kissei Pharmaceutical Co., Ltd. under Pharmaceuticals & Biotechnology - Specialty Pharmaceuticals in its company registry.

Kissei Pharmaceutical is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products, including the collection and analysis of medicine development information. The company focuses on d...

6/ 10Solid

Cyborg Score thesis

Focused specialty pharma player with strong R&D orientation in niche therapeutic areas showing steady revenue growth and...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Biotechnology - Specialty Pharmaceuticals
2 named competitors
1 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Kissei Pharmaceutical Co., Ltd. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Kissei Pharmaceutical Co., Ltd.

AskCyborg analysts argue the bull and bear cases for Kissei Pharmaceutical Co., Ltd. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Kissei Pharmaceutical Co., Ltd. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Kissei Pharmaceutical Co., Ltd. Overview

Pro stress-test →

Kissei Pharmaceutical is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products, including the collection and analysis of medicine development information. The company focuses on drug discovery and licensing activities within specialized therapeutic areas, including urology, nephrology/dialysis, and rare diseases.

Strategic Profile

Pro stress-test →

As a strong R&D-oriented corporation, it concentrates on providing innovative pharmaceuticals to patients worldwide. The company has sales offices across Japan and an overseas subsidiary in New Jersey, the US. Kissei actively pursues innovative approaches in drug development, leveraging advanced technologies such as AI drug discovery and natural language processing to accelerate its research pipeline.

Competitive Landscape

Pro stress-test →

The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei competes as a mid-tier specialty pharmaceutical player focusing on niche therapeutic areas, positioning itself against larger diversified pharma companies and other specialty drug manufacturers.

Industry Context

Kissei Pharmaceutical Co., Ltd. operates in Pharmaceuticals & Biotechnology - Specialty Pharmaceuticals.

Key facts

Founded: 1946 · Headquarters: Matsumoto, Japan · Employees: 1,778 · Revenue: $611.3M (2025) · Market cap: $1.4B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Kissei Pharmaceutical Co., Ltd..

  • Specialized focus on urology, nephrology/dialysis, and rare diseases provides competitive differentiation in underserved market segments
  • Active use of AI drug discovery and advanced technologies demonstrates commitment to modern drug development approaches
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2020Exclusive license agreement with CG Oncology for oncolytic immunotherapy drug CG0070 in Japan and select Asian countries
Get alerted when Kissei Pharmaceutical Co., Ltd. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Specialty PharmaceuticalsLarger Japanese pharmaceutical conglomerate with broader portfolio→Rare Disease FocusGlobal players targeting similar rare disease and specialized therapeutic areas→

Compare Kissei Pharmaceutical Co., Ltd. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Kissei Pharmaceutical Co., Ltd. operates in Pharmaceuticals & Biotechnology - Specialty Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Biotechnology - Specialty Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Kissei Pharmaceutical Co., Ltd.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Kissei Pharmaceutical Co., Ltd. and its top competitor on Cyborg Score”
“What did Kissei Pharmaceutical Co., Ltd. do this quarter?”
“Is Kissei Pharmaceutical Co., Ltd. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Kissei Pharmaceutical Co., Ltd. do?+
Kissei Pharmaceutical is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products, including the collection and analysis of medicine development information. The company focuses on d...
What is Kissei Pharmaceutical Co., Ltd.'s Cyborg Score?+
Kissei Pharmaceutical Co., Ltd. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Kissei Pharmaceutical Co., Ltd.'s main competitors?+
Named competitors include Specialty Pharmaceuticals, Rare Disease Focus. The full competitive landscape is in the AskCyborg report.
How can I get the full Kissei Pharmaceutical Co., Ltd. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Kissei Pharmaceutical Co., Ltd. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Kissei Pharmaceutical Co., Ltd. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.